Revenue from Contracts with Customers

6 Months Ended

Jun. 30, 2023

Revenue from Contract with Customer [Abstract]

Revenue from Contracts with Customers

3.   Revenue from Contracts with Customers. We recognize revenue when a customer obtains control of promised goods. The amount of revenue recognized reflects the consideration we expect to receive in exchange for these goods. Our revenue recognition policies have not changed from those disclosed in Note 1 to our consolidated financial statements in Item 8 of the 2022 Annual Report on Form 10-K.

Disaggregation of Revenue

Our revenue is disaggregated based on reporting segment, product category and geographical region. We design, develop, manufacture and market medical products for interventional and diagnostic procedures. For financial reporting purposes, we report our operations in two operating segments: cardiovascular and endoscopy. Our cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer (“OEM”). Within these product categories, we sell a variety of products, including cardiology and radiology devices (which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases), as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, and interventional oncology and spine devices. Our endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.

The following tables present revenue from contracts with customers by reporting segment, product category and geographical region for the three and six-month periods ended June 30, 2023 and 2022 (in thousands):

	Three Months Ended						Three Months Ended
	June 30, 2023						June 30, 2022
	United States		International		Total		United States		International		Total
Cardiovascular
Peripheral Intervention	$	71,973	$	53,936	$	125,909	$	65,795		45,160	$	110,955
Cardiac Intervention		35,690		58,085		93,775		33,909		55,665		89,574
Custom Procedural Solutions		29,155		20,229		49,384		27,318		21,775		49,093
OEM		34,570		7,637		42,207		30,048		7,000		37,048
Total		171,388		139,887		311,275		157,070		129,600		286,670
Endoscopy
Endoscopy Devices		8,194		587		8,781		7,604		702		8,306
Total	$	179,582	$	140,474	$	320,056	$	164,674	$	130,302	$	294,976

	Six Months Ended						Six Months Ended
	June 30, 2023						June 30, 2022
	United States		International		Total		United States		International		Total
Cardiovascular
Peripheral Intervention	$	140,640	$	99,052	$	239,692	$	127,895	$	88,833	$	216,728
Cardiac Intervention		69,995		109,108		179,103		62,458		108,603		171,061
Custom Procedural Solutions		55,954		41,131		97,085		53,873		41,482		95,355
OEM		67,134		16,237		83,371		57,844		12,618		70,462
Total		333,723		265,528		599,251		302,070		251,536		553,606
Endoscopy
Endoscopy Devices		17,219		1,151		18,370		15,596		1,189		16,785
Total	$	350,942	$	266,679	$	617,621	$	317,666	$	252,725	$	570,391